Table 1

Participant demographic, clinical, and anthropometric characteristics, by HIV status.

VariablenTotal (n = 393)HIV– (n = 200)HIV+ (n = 193)p
Sociodemographic data, n (%)
Age groups
  40-44 y
  45-49 y
  50-54 y
  55-60 y
39394 (23.9)
103 (26.2)
100 (25.5)
96 (24.4)
51 (25.5)
49 (24.5)
50 (25.0)
50 (25.0)
43 (22.3)
54 (28.0)
50 (25.9)
46 (23.8)
.810
Socioeconomic status quintiles
  Q1
  Q2
  Q3
  Q4
  Q5
39381 (20.6)
77 (19.6)
79 (20.1)
79 (20.1)
77 (19.6)
36 (18.0)
42 (21.0)
39 (19.5)
36 (18.0)
47 (23.5)
45 (23.3)
35 (18.1)
40 (20.7)
43 (22.3)
30 (15.5)
.208
Menopause status
  Pre and peri
  Post
393221 (56.2)
172 (43.8)
119 (59.5)
81 (40.5)
102 (52.8)
91 (47.2)
.184
Parity
  Nulliparous (0)
  Low parity (1-3)
  Multiparous (≥4)
39310 (2.5)
242 (61.6)
141 (35.9)
2 (1.0)
117 (58.5)
81 (40.5)
8 (4.1)
125 (64.8)
60 (31.1)
.032
Hysterectomy39321 (5.3)10 (5.0)11 (5.7).825
Current contraception use393111 (28.4)66 (33.0)45 (23.3).033
Current Depo-Provera use39325 (6.4)16 (8.0)9 (4.7).040
Highest level of education
  None/primary
  Secondary
  Tertiary
39362 (15.8)
267 (67.9)
64 (16.3)
35 (17.5)
117 (58.5)
48 (24.0)
27 (14.0)
150 (77.7)
16 (8.3)
<.001
Currently employed393202 (51.4)133 (66.5)69 (35.8)<.001
Worry of food insecurity in the household393271 (69.0)126 (63.0)145 (75.1).009
FRAX risk factors, n (%)
Ever smoked3936 (1.5)1 (0.5)5 (2.6).116
Current alcohol intake39330 (7.6)14 (7.0)16 (8.3).706
Parental hip fracture39333 (8.4)15 (7.5)18 (9.3).514
Fracture history, n (%)
Ever fractured39341 (7.0)14 (7.0)27 (14.0).023
Hip fracture3933 (0.8)03 (1.5).117
Major osteoporotic fracture39319 (4.8)5 (2.5)14 (7.3).028
Fragility fracture39325 (6.4)8 (4.0)17 (8.8).051
FRAX probability
Ten-year major osteoporotic fragility fracture,  median (IQR)3931.1 (0.9-1.6)1.0 (0.9-1.5)1.2 (0.9-1.8).001
Anthropometry
Weight, mean (SD), kg39375.7 (16.3)80.8 (16.1)70.3 (14.8)<.001
Height, mean (SD), cm393161.5 (5.6)162.0 (5.4)160.9 (5.8).044
BMI (kg/m2), n (%)
  Underweight (<18.5)
  Normal (18.5 < 25)
  Overweight (25 < 30)
  Obese (≥30)
3936 (1.5)
95 (24.2)
135 (34.3)
157 (40.0)
0
35 (17.5)
63 (31.5)
102 (51.0)
6 (3.1)
60 (31.1)
72 (37.3)
55 (28.5)
<.001
HIV characteristics
Established on ART, n (%)193184 (95.3)184 (95.3)
Established on TDF-based ART regimen, n (%)184156 (84.8)156 (84.8)
ART duration, median (IQR), y1849 (5-13)9 (5-13)
Current HIV viral load (≥50 copies/mL), n (%)19337 (19.2)37 (19.2)
VariablenTotal (n = 393)HIV– (n = 200)HIV+ (n = 193)p
Sociodemographic data, n (%)
Age groups
  40-44 y
  45-49 y
  50-54 y
  55-60 y
39394 (23.9)
103 (26.2)
100 (25.5)
96 (24.4)
51 (25.5)
49 (24.5)
50 (25.0)
50 (25.0)
43 (22.3)
54 (28.0)
50 (25.9)
46 (23.8)
.810
Socioeconomic status quintiles
  Q1
  Q2
  Q3
  Q4
  Q5
39381 (20.6)
77 (19.6)
79 (20.1)
79 (20.1)
77 (19.6)
36 (18.0)
42 (21.0)
39 (19.5)
36 (18.0)
47 (23.5)
45 (23.3)
35 (18.1)
40 (20.7)
43 (22.3)
30 (15.5)
.208
Menopause status
  Pre and peri
  Post
393221 (56.2)
172 (43.8)
119 (59.5)
81 (40.5)
102 (52.8)
91 (47.2)
.184
Parity
  Nulliparous (0)
  Low parity (1-3)
  Multiparous (≥4)
39310 (2.5)
242 (61.6)
141 (35.9)
2 (1.0)
117 (58.5)
81 (40.5)
8 (4.1)
125 (64.8)
60 (31.1)
.032
Hysterectomy39321 (5.3)10 (5.0)11 (5.7).825
Current contraception use393111 (28.4)66 (33.0)45 (23.3).033
Current Depo-Provera use39325 (6.4)16 (8.0)9 (4.7).040
Highest level of education
  None/primary
  Secondary
  Tertiary
39362 (15.8)
267 (67.9)
64 (16.3)
35 (17.5)
117 (58.5)
48 (24.0)
27 (14.0)
150 (77.7)
16 (8.3)
<.001
Currently employed393202 (51.4)133 (66.5)69 (35.8)<.001
Worry of food insecurity in the household393271 (69.0)126 (63.0)145 (75.1).009
FRAX risk factors, n (%)
Ever smoked3936 (1.5)1 (0.5)5 (2.6).116
Current alcohol intake39330 (7.6)14 (7.0)16 (8.3).706
Parental hip fracture39333 (8.4)15 (7.5)18 (9.3).514
Fracture history, n (%)
Ever fractured39341 (7.0)14 (7.0)27 (14.0).023
Hip fracture3933 (0.8)03 (1.5).117
Major osteoporotic fracture39319 (4.8)5 (2.5)14 (7.3).028
Fragility fracture39325 (6.4)8 (4.0)17 (8.8).051
FRAX probability
Ten-year major osteoporotic fragility fracture,  median (IQR)3931.1 (0.9-1.6)1.0 (0.9-1.5)1.2 (0.9-1.8).001
Anthropometry
Weight, mean (SD), kg39375.7 (16.3)80.8 (16.1)70.3 (14.8)<.001
Height, mean (SD), cm393161.5 (5.6)162.0 (5.4)160.9 (5.8).044
BMI (kg/m2), n (%)
  Underweight (<18.5)
  Normal (18.5 < 25)
  Overweight (25 < 30)
  Obese (≥30)
3936 (1.5)
95 (24.2)
135 (34.3)
157 (40.0)
0
35 (17.5)
63 (31.5)
102 (51.0)
6 (3.1)
60 (31.1)
72 (37.3)
55 (28.5)
<.001
HIV characteristics
Established on ART, n (%)193184 (95.3)184 (95.3)
Established on TDF-based ART regimen, n (%)184156 (84.8)156 (84.8)
ART duration, median (IQR), y1849 (5-13)9 (5-13)
Current HIV viral load (≥50 copies/mL), n (%)19337 (19.2)37 (19.2)

All continuous variables are described as mean (SD), unless otherwise stated; all categorical variables are presented as a frequency (%). Twenty-one (5.3%) of the women had a hysterectomy.

Abbreviations: ART, antiretroviral therapy; TDF, tenofovir disoproxil fumarate.

Table 1

Participant demographic, clinical, and anthropometric characteristics, by HIV status.

VariablenTotal (n = 393)HIV– (n = 200)HIV+ (n = 193)p
Sociodemographic data, n (%)
Age groups
  40-44 y
  45-49 y
  50-54 y
  55-60 y
39394 (23.9)
103 (26.2)
100 (25.5)
96 (24.4)
51 (25.5)
49 (24.5)
50 (25.0)
50 (25.0)
43 (22.3)
54 (28.0)
50 (25.9)
46 (23.8)
.810
Socioeconomic status quintiles
  Q1
  Q2
  Q3
  Q4
  Q5
39381 (20.6)
77 (19.6)
79 (20.1)
79 (20.1)
77 (19.6)
36 (18.0)
42 (21.0)
39 (19.5)
36 (18.0)
47 (23.5)
45 (23.3)
35 (18.1)
40 (20.7)
43 (22.3)
30 (15.5)
.208
Menopause status
  Pre and peri
  Post
393221 (56.2)
172 (43.8)
119 (59.5)
81 (40.5)
102 (52.8)
91 (47.2)
.184
Parity
  Nulliparous (0)
  Low parity (1-3)
  Multiparous (≥4)
39310 (2.5)
242 (61.6)
141 (35.9)
2 (1.0)
117 (58.5)
81 (40.5)
8 (4.1)
125 (64.8)
60 (31.1)
.032
Hysterectomy39321 (5.3)10 (5.0)11 (5.7).825
Current contraception use393111 (28.4)66 (33.0)45 (23.3).033
Current Depo-Provera use39325 (6.4)16 (8.0)9 (4.7).040
Highest level of education
  None/primary
  Secondary
  Tertiary
39362 (15.8)
267 (67.9)
64 (16.3)
35 (17.5)
117 (58.5)
48 (24.0)
27 (14.0)
150 (77.7)
16 (8.3)
<.001
Currently employed393202 (51.4)133 (66.5)69 (35.8)<.001
Worry of food insecurity in the household393271 (69.0)126 (63.0)145 (75.1).009
FRAX risk factors, n (%)
Ever smoked3936 (1.5)1 (0.5)5 (2.6).116
Current alcohol intake39330 (7.6)14 (7.0)16 (8.3).706
Parental hip fracture39333 (8.4)15 (7.5)18 (9.3).514
Fracture history, n (%)
Ever fractured39341 (7.0)14 (7.0)27 (14.0).023
Hip fracture3933 (0.8)03 (1.5).117
Major osteoporotic fracture39319 (4.8)5 (2.5)14 (7.3).028
Fragility fracture39325 (6.4)8 (4.0)17 (8.8).051
FRAX probability
Ten-year major osteoporotic fragility fracture,  median (IQR)3931.1 (0.9-1.6)1.0 (0.9-1.5)1.2 (0.9-1.8).001
Anthropometry
Weight, mean (SD), kg39375.7 (16.3)80.8 (16.1)70.3 (14.8)<.001
Height, mean (SD), cm393161.5 (5.6)162.0 (5.4)160.9 (5.8).044
BMI (kg/m2), n (%)
  Underweight (<18.5)
  Normal (18.5 < 25)
  Overweight (25 < 30)
  Obese (≥30)
3936 (1.5)
95 (24.2)
135 (34.3)
157 (40.0)
0
35 (17.5)
63 (31.5)
102 (51.0)
6 (3.1)
60 (31.1)
72 (37.3)
55 (28.5)
<.001
HIV characteristics
Established on ART, n (%)193184 (95.3)184 (95.3)
Established on TDF-based ART regimen, n (%)184156 (84.8)156 (84.8)
ART duration, median (IQR), y1849 (5-13)9 (5-13)
Current HIV viral load (≥50 copies/mL), n (%)19337 (19.2)37 (19.2)
VariablenTotal (n = 393)HIV– (n = 200)HIV+ (n = 193)p
Sociodemographic data, n (%)
Age groups
  40-44 y
  45-49 y
  50-54 y
  55-60 y
39394 (23.9)
103 (26.2)
100 (25.5)
96 (24.4)
51 (25.5)
49 (24.5)
50 (25.0)
50 (25.0)
43 (22.3)
54 (28.0)
50 (25.9)
46 (23.8)
.810
Socioeconomic status quintiles
  Q1
  Q2
  Q3
  Q4
  Q5
39381 (20.6)
77 (19.6)
79 (20.1)
79 (20.1)
77 (19.6)
36 (18.0)
42 (21.0)
39 (19.5)
36 (18.0)
47 (23.5)
45 (23.3)
35 (18.1)
40 (20.7)
43 (22.3)
30 (15.5)
.208
Menopause status
  Pre and peri
  Post
393221 (56.2)
172 (43.8)
119 (59.5)
81 (40.5)
102 (52.8)
91 (47.2)
.184
Parity
  Nulliparous (0)
  Low parity (1-3)
  Multiparous (≥4)
39310 (2.5)
242 (61.6)
141 (35.9)
2 (1.0)
117 (58.5)
81 (40.5)
8 (4.1)
125 (64.8)
60 (31.1)
.032
Hysterectomy39321 (5.3)10 (5.0)11 (5.7).825
Current contraception use393111 (28.4)66 (33.0)45 (23.3).033
Current Depo-Provera use39325 (6.4)16 (8.0)9 (4.7).040
Highest level of education
  None/primary
  Secondary
  Tertiary
39362 (15.8)
267 (67.9)
64 (16.3)
35 (17.5)
117 (58.5)
48 (24.0)
27 (14.0)
150 (77.7)
16 (8.3)
<.001
Currently employed393202 (51.4)133 (66.5)69 (35.8)<.001
Worry of food insecurity in the household393271 (69.0)126 (63.0)145 (75.1).009
FRAX risk factors, n (%)
Ever smoked3936 (1.5)1 (0.5)5 (2.6).116
Current alcohol intake39330 (7.6)14 (7.0)16 (8.3).706
Parental hip fracture39333 (8.4)15 (7.5)18 (9.3).514
Fracture history, n (%)
Ever fractured39341 (7.0)14 (7.0)27 (14.0).023
Hip fracture3933 (0.8)03 (1.5).117
Major osteoporotic fracture39319 (4.8)5 (2.5)14 (7.3).028
Fragility fracture39325 (6.4)8 (4.0)17 (8.8).051
FRAX probability
Ten-year major osteoporotic fragility fracture,  median (IQR)3931.1 (0.9-1.6)1.0 (0.9-1.5)1.2 (0.9-1.8).001
Anthropometry
Weight, mean (SD), kg39375.7 (16.3)80.8 (16.1)70.3 (14.8)<.001
Height, mean (SD), cm393161.5 (5.6)162.0 (5.4)160.9 (5.8).044
BMI (kg/m2), n (%)
  Underweight (<18.5)
  Normal (18.5 < 25)
  Overweight (25 < 30)
  Obese (≥30)
3936 (1.5)
95 (24.2)
135 (34.3)
157 (40.0)
0
35 (17.5)
63 (31.5)
102 (51.0)
6 (3.1)
60 (31.1)
72 (37.3)
55 (28.5)
<.001
HIV characteristics
Established on ART, n (%)193184 (95.3)184 (95.3)
Established on TDF-based ART regimen, n (%)184156 (84.8)156 (84.8)
ART duration, median (IQR), y1849 (5-13)9 (5-13)
Current HIV viral load (≥50 copies/mL), n (%)19337 (19.2)37 (19.2)

All continuous variables are described as mean (SD), unless otherwise stated; all categorical variables are presented as a frequency (%). Twenty-one (5.3%) of the women had a hysterectomy.

Abbreviations: ART, antiretroviral therapy; TDF, tenofovir disoproxil fumarate.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close